The U.S. Food and Drug Administration approved 2025-26 COVID-19 vaccines for anyone age 65 and older and any person 6 months and older who has at least one underlying health condition that increases ...

As Covid-19 transmission ramps up in the United States, recent changes to federal vaccine guidance have left many Americans confused about the latest policies and concerned about access to shots this ...

COVID-19 variant BA.3.2 or "cicada" is not widely circulating in the U.S. yet, but based on trends in Europe, it may become more prominent. Most evidence comes from laboratory data, but there are no ...

The US Food and Drug Administration (FDA) has green-lit updated COVID-19 vaccines for the 2025–26 season for select groups, but confusion is already mounting over how physicians and insurers will ...

In a new study published in Nature Immunology, researchers at Boston Children's Hospital demonstrated that pairing the ...

School closures during the COVID-19 pandemic imposed enormous long-term costs while other measures delivered better health outcomes for far less money, according to new research led by Oxford ...

People are spiraling into health anxiety amid the hantavirus outbreak. Experts explain why, and share tips on how to cope.

Dr. Omer Awan details lessons from COVID-19 that should be driving the U.S. response in order to contain the Andes hantavirus ...

Investigators have been looking at a handful of Chinese firms that together control the majority of unrefrigerated shipping ...